Study finds health care evaluations of large language models lacking in real patient data and bias assessment

A pa­tient group this sum­mer ac­cused Taysha Gene Ther­a­pies of breach­ing a con­tract to de­vel­op a ther­a­py for an ul­tra-rare con­di­tion, an­oth­er sign of deep

Astel­las Phar­ma is sign­ing Po­sei­da Ther­a­peu­tics to a sec­ond deal fo­cused on de­vel­op­ing off-the-shelf sol­id tu­mor cell ther­a­pies af­ter the com­pa­nies first teamed up in